Document text
MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda
Cent
ers for Disease Control and Prevention
Atlanta, GA
Thursday, September 18, 2025
10:00 AM Welcome and Roll Call Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
10:30 AM Update on Work Groups Dr. Martin Kulldorff (ACIP Chair)
10:40 AM Measles, Mumps, Rubella, and Varicella
(MMRV) Vaccines
Introduction Dr. Martin Kulldorff (ACIP Chair)
Background on MMRV Dr. Arjun Srinivasan (CDC/NCIRD)
Presentation on febrile seizure following
MMRV vaccine Dr. John Su (CDC/NCEZID)
MMRV Vaccine Manufacturer Statements TBD
Proposed recommendations and discussion Dr. Martin Kulldorff (ACIP Chair)
VFC presentation Dr. Jeanne Santoli (CDC/NCIRD)
12:35 PM Lunch
1:05 PM Hepatitis B Vaccine
Introduction Dr. Martin Kulldorff (ACIP Chair)
Presentation on Hepatitis B Birth Dose
Vaccination Dr. Adam Langer (CDC/NCHHSTP)
Hep B vaccine safety updates Dr. John Su (CDC/NCEZID)
Hep B Vaccine Manufacturer Statements TBD
Proposed recommendations and discussion Dr. Martin Kulldorff (ACIP Chair)
VFC presentation Dr. Jeanne Santoli (CDC/NCIRD)
3:55 PM Break
4:10 PM Agency Updates CDC, CMS, FDA, HRSA, IHS, NIH
4:30 PM Public Comment
5:00 PM Votes
MMRV vaccines Dr. Martin Kulldorff (ACIP Chair)
MMRV vaccines - VFC Dr. Jeanne Santoli (CDC/NCIRD)
Hepatitis B vaccines Dr. Martin Kulldorff (ACIP Chair)
Hepatitis B vaccines – VFC Dr. Jeanne Santoli (CDC/NCIRD)
5:30 PM Adjourn
MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda
Friday, September 19, 2025
8:30 AM Welcome and Roll Call Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
8:40 AM COVID -19 Vaccines
Introduction Dr. Retsef Levi (ACIP WG Chair)
COVID -19 epidemiology update Dr. Arjun Srinivasan (CDC/NCIRD)
Updates to 2024 -2025 COVID -19
Implementation Considerations Dr. Arjun Srinivasan (CDC/NCIRD)
COVID -19 vaccine effectiveness update Dr. Arjun Srinivasan (CDC/NCIRD)
COVID -19 vaccine safety update Dr. John Su (CDC/NCEZID)
10:05 AM Break
10:10 AM COVID -19 Vaccines (continued)
Workgroup Safety Uncertainties of mRNA
COVID Vaccines Dr. Wafik El -Deiry & Dr. Charlotte Kuperwasser
(COVID -19 Workgroup Member)
Genomics of Vaccine -Induced Myocarditis Dr. Bruce Carleton (COVID -19 Workgroup Member)
Economic analysis of COVID -19 vaccination Dr. Arjun Srinivasan (CDC/NCIRD) on behalf of the
University of Michigan
COVID -19 Vaccine Manufacturer Statements TBD
11:40 AM Lunch
12:00 PM COVID -19 Vaccines (continued)
COVID -19 Discussion Framing Dr. Retsef Levi (ACIP WG Chair)
Proposed recommendations and discussion Dr. Retsef Levi (ACIP WG Chair)
1:40 PM Break
1:45 PM Public Comment
2:15 PM Votes
COVID -19 Vaccines Dr. Retsef Levi (ACIP WG Chair)
3:00 PM Adjourn
Acronyms
CDC Centers for Disease Control and Prevention
CMS Centers for Medicare & Medicaid Services
COVID-19 Coronavirus disease 2019
FDA Food and Drug Administration
HRSA Health Resources and Services Administration
IHS Indian Health Service MMRV Measles, Mumps, Rubella, Varicella Vaccine NCIRD National Center for Immunization & Respiratory Diseases
NCEZID National Center for Emerging and Zoonotic Diseases NCHHSTP National Center for HIV , Viral Hepatitis, STD, and Tuberculosis Prevention NIH National Institutes of Health
VFC Vaccines for Children